Replies to post #125822 on Biotech Values

[DewDiligence]

ILNS—I hope bapi gets approved. 5% royalites (approx)to ILNS, that's 50 million for every billion.

Where is the concrete evidence that ILNS will get material royalties—or any royalties at all—on sales of Bapineuzumab? By concrete evidence I mean a contractual agreement filed with the SEC, not some unsupported assertion by ILNS management.